Önder Alpdoğan

机构：Thomas Jefferson University, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center · ORCID：0000-0002-4832-5344

发表论文 200 篇 · 总被引 5521 次 · h-index 34

代表论文

• Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study (2023 · Blood Advances · 被引 50)
• Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma (2024 · Molecular and Clinical Oncology · 被引 7)
• High local control and low ocular toxicity using ultra-low-dose “boom-boom” radiotherapy for indolent orbital lymphoma (2022 · Chinese Clinical Oncology · 被引 7)
• Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor (2022 · Case Reports in Oncology · 被引 6)
• Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma (2025 · Blood Advances · 被引 2)
• Coexistence of large cell transformed mycosis fungoides and diffuse large B‐cell lymphoma in one patient (2024 · Journal of Cutaneous Pathology · 被引 2)